The trajectory of Sildenafil presents a nuanced case for stakeholders in the pharmaceutical sector. While initially a tremendous success, creating billions, the patent expiration and the subsequent flood of cheaper https://pharma477893.affiliatblogger.com/94196455/the-little-copyright-and-the-pharmaceutical-industry-a-speculative-investment